Total Pageviews

Tuesday, June 17, 2025

Costs...

 

Regulators have been trying to get pharmaceutical companies to reign in prices for years.   This crap with the orange stain & his funding cuts has made it even more imperative.  This piece is about Gilead's Lenacapavir.    

This med is currently to be marketed for between upper 30K & lower 40K annually.  Research found the med could be made for as little as $40 annually if 2 million doses were sold yearly.  If the more of the drug was produced the price would fall.

It could, be made for only $25 (£18.40) a year – including a 30% profit margin – analysis from the University of Liverpool and others suggests.

At the original price, even affluent nations couldn't afford the medicine.  Estimates have 1M+ people in the US using PrEP.  The numbers are there.  Then include the nearly 40M living with HIV & this drug, or meds like it, could be made very affordable.

Unfortunately as long as conservatives, religious bigots & greedy people exists, HIV & other illnesses will never be cured or eradicated.  They're just too profitable.  Corporate avarice & political corruption are the illnesses we all suffer from.

That's all for now.  

Take care.

Cya...

No comments:

Post a Comment